$VUZI
Vuzix Corp Stock $vuzi

$vuzi Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415049041 Filed on August 13, 2015

Income Statement

Concept	2015 Q2	2014 Q4	2014 Q2
Revenue	$427.8K	$850.0K	$723.3K
YoY Change	-40.85%	39.34%	3.29%
Cost Of Revenue	$392.5K	$730.0K	$462.2K
YoY Change	-15.08%	12.31%	13.68%
Gross Profit	$35.26K	$120.0K	$261.0K
YoY Change	-86.49%	-400.0%	-11.09%
Gross Profit Margin	8.24%	14.12%	36.09%
Selling, General & Admin	$1.369M	$1.260M	$789.3K
YoY Change	73.38%	40.0%	-11.31%
% of Gross Profit	3880.75%	1050.0%	302.4%
Research & Development	$732.5K	$580.0K	$295.6K
YoY Change	147.84%	7.41%	-29.8%
% of Gross Profit	2077.16%	483.33%	113.23%
Depreciation & Amortization	$150.0K	$90.00K	$100.0K
YoY Change	50.0%	-10.0%	11.11%
% of Gross Profit	425.36%	75.0%	38.31%
Operating Expenses	$2.101M	$1.850M	$1.085M
YoY Change	93.66%	20.92%	157.68%
Operating Profit	-$2.144M	-$1.730M	-$925.3K
YoY Change	131.74%	10.19%	-16.48%
Interest Expense	$37.69K	-$4.480M	$25.47K
YoY Change	47.98%	34.53%	-88.99%
% of Operating Profit
Other Income/Expense, Net	-$258.0K	-$30.00K	$1.164M
YoY Change	-122.16%	-105.45%	-312.15%
Pretax Income	-$2.402M	-$6.320M	$239.1K
YoY Change	-1104.7%	10.1%	-114.43%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$2.402M	-$6.320M	$239.1K
YoY Change	-1104.7%	10.88%	-114.43%
Net Earnings / Revenue	-561.54%	-743.53%	33.06%
Basic Earnings Per Share	-$0.17		$0.02
Diluted Earnings Per Share	-$0.17	-$570.4K	$0.02
COMMON SHARES
Basic Shares Outstanding	15.93M shares	11.15M shares	10.29M shares
Diluted Shares Outstanding	15.93M shares		11.23M shares

Balance Sheet

Concept	2015 Q2	2014 Q4	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.00M	$100.0K	$2.000M
YoY Change	900.0%	-66.67%	1900.0%
Cash & Equivalents	$15.05M	$84.97K	$1.979M
Short-Term Investments	$5.000M
Other Short-Term Assets	$1.400M	$600.0K	$100.0K
YoY Change	1300.0%	200.0%	-75.0%
Inventory	$1.087M	$900.0K	$916.8K
Prepaid Expenses
Receivables	$84.38K	$400.0K	$166.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.60M	$1.959M	$3.115M
YoY Change	625.5%	16.66%	155.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$500.0K	$417.0K	$353.6K
YoY Change	41.39%	-6.58%	-31.04%
Goodwill
YoY Change
Intangibles	$514.3K	$423.5K	$514.6K
YoY Change	-0.06%	-14.55%	-6.69%
Long-Term Investments
YoY Change
Other Assets	$89.49K	$112.5K	$134.7K
YoY Change	-33.56%		-32.66%
Total Long-Term Assets	$1.701M	$1.628M	$1.726M
YoY Change	-1.45%	37.69%	34.57%
TOTAL ASSETS
Total Short-Term Assets	$22.60M	$1.959M	$3.115M
Total Long-Term Assets	$1.701M	$1.628M	$1.726M
Total Assets	$24.30M	$3.588M	$4.841M
YoY Change	401.99%	25.35%	93.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$700.0K	$2.184M	$2.093M
YoY Change	-66.55%	-9.79%	-40.2%
Accrued Expenses	$719.8K	$699.1K	$582.7K
YoY Change	23.54%	18.25%	-47.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$100.0K	$200.0K
YoY Change	-100.0%	-66.67%	-66.67%
Long-Term Debt Due	$100.0K	$128.4K	$100.0K
YoY Change	0.0%	29.3%	-94.12%
Total Short-Term Liabilities	$1.594M	$3.387M	$3.114M
YoY Change	-48.82%	-7.49%	-60.81%
LONG-TERM LIABILITIES
Long-Term Debt	$1.100M	$1.089M	$1.208M
YoY Change	-8.92%	538.72%	-8.44%
Other Long-Term Liabilities	$300.0K	$13.60M	$9.000M
YoY Change	-96.67%	12.4%	373.68%
Total Long-Term Liabilities	$1.372M	$14.71M	$10.20M
YoY Change	-86.55%	20.2%	214.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.594M	$3.387M	$3.114M
Total Long-Term Liabilities	$1.372M	$14.71M	$10.20M
Total Liabilities	$2.966M	$18.10M	$13.31M
YoY Change	-77.72%	13.82%	18.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.65M	-$44.16M	-$34.54M
YoY Change	49.54%	21.68%
Common Stock		$11.30K	$10.32K
YoY Change		17.67%	191.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.37M	-$14.40M	-$8.472M
YoY Change
Total Liabilities & Shareholders Equity	$24.33M	$3.588M	$4.841M
YoY Change	402.69%	25.35%	93.9%

Cashflow Statement

Concept	2015 Q2	2014 Q4	2014 Q2
OPERATING ACTIVITIES
Net Income	-$2.402M	-$6.320M	$239.1K
YoY Change	-1104.7%	10.88%	-114.43%
Depreciation, Depletion And Amortization	$150.0K	$90.00K	$100.0K
YoY Change	50.0%	-10.0%	11.11%
Cash From Operating Activities	-$2.540M	-$1.260M	-$910.0K
YoY Change	179.12%	-43.75%	89.58%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	$0.00	-$260.0K
YoY Change	3.85%	-100.0%	2500.0%
Acquisitions
YoY Change
Other Investing Activities	-$5.000M
YoY Change
Cash From Investing Activities	-$5.270M	$0.00	-$260.0K
YoY Change	1926.92%	-100.0%	2500.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.00K	780.0K	2.870M
YoY Change	-100.7%	160.0%	7075.0%
NET CHANGE
Cash From Operating Activities	-2.540M	-1.260M	-910.0K
Cash From Investing Activities	-5.270M	0.000	-260.0K
Cash From Financing Activities	-20.00K	780.0K	2.870M
Net Change In Cash	-7.830M	-480.0K	1.700M
YoY Change	-560.59%	-78.76%	-477.78%
FREE CASH FLOW
Cash From Operating Activities	-$2.540M	-$1.260M	-$910.0K
Capital Expenditures	-$270.0K	$0.00	-$260.0K
Free Cash Flow	-$2.270M	-$1.260M	-$650.0K
YoY Change	249.23%	-34.38%	38.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	719837	USD
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6732	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1593902	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1088996	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	81451	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	125405	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1371984	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	1959449	USD
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	514295	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	22599352	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	252331	USD
CY2015Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2014Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	112500	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	536373	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14711585	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3700162	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-14398011	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7493179	USD
	vuzi	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	1217626	USD
	vuzi	Adjustment To Addional Paid In Capital Reclassification Of Warrant Exercises AdjustmentToAddionalPaidInCapitalReclassificationOfWarrantExercises	2855463	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	472500	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	583664	USD
	vuzi	Adjustment To Addional Paid In Capital Reclassification Of Warrant Liability AdjustmentToAddionalPaidInCapitalReclassificationOfWarrantLiability	8736412	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1475000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	260373	USD
	vuzi	Adjustments To Additional Paid In Capital Reclassification Of Fair Value Of Note Derivative Liability AdjustmentsToAdditionalPaidInCapitalReclassificationOfFairValueOfNoteDerivativeLiability	2806942	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	1086838	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84380	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	37693	USD
CY2015Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-258046	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q4	us-gaap	Liabilities Liabilities	18098173	USD
CY2015Q2	us-gaap	Interest Payable Current InterestPayableCurrent	18171	USD
CY2015Q2	us-gaap	Liabilities Liabilities	2965886	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24333838	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	11296	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29752083	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	21367952	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51654569	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	13541138	USD
CY2015Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	169027	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	16882	USD
CY2015Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	6009	USD
CY2014Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	787738	USD
CY2015Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	644513	USD
CY2015Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	89488	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112521	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	68591	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	53403	USD
CY2015Q2	us-gaap	Notes Payable NotesPayable	0	USD
CY2014Q4	us-gaap	Notes Payable NotesPayable	37038	USD
CY2015Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent	21872	USD
CY2014Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	120550	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	295552	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	214169	USD
	vuzi	Adjustments To Additional Paid In Capital Proceeds From Preferred Stock Offering Value AdjustmentsToAdditionalPaidInCapitalProceedsFromPreferredStockOfferingValue	24813000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	427812	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	609887	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	392548	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	416808	USD
CY2015Q2	us-gaap	Cost Of Services CostOfServices	0	USD
CY2014Q2	us-gaap	Cost Of Services CostOfServices	45432	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	392548	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	462240	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	35264	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	261018	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	732491	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	345262	USD
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	256767	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1023244	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	532561	USD
CY2015Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	78548	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101438	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2144281	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-925300	USD
CY2015Q2	us-gaap	Taxes Other TaxesOther	2290	USD
CY2014Q2	us-gaap	Taxes Other TaxesOther	25093	USD
CY2015Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-23279	USD
CY2014Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1248556	USD
CY2015Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	178981	USD
CY2014Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	33889	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	25472	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1164410	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2402327	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	239110	USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-2402327	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	239110	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11226921	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15934279	shares
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1123386	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1259305	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	113581	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	262371	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1236967	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1521676	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	977938	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	807457	USD
	us-gaap	Cost Of Services CostOfServices	45432	USD
	us-gaap	Cost Of Services CostOfServices	105032	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1023370	USD
	us-gaap	Cost Of Revenue CostOfRevenue	912489	USD
	us-gaap	Gross Profit GrossProfit	213597	USD
	us-gaap	Gross Profit GrossProfit	609187	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1247198	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	692974	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	702809	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	621322	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3958149	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1012197	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	138187	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	201143	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5832746	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1918449	USD
	us-gaap	Taxes Other TaxesOther	14065	USD
	us-gaap	Taxes Other TaxesOther	46535	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1048	USD
	us-gaap	Depreciation Depreciation	138187	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	252331	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-237	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1026706	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	3823818	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	519941	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	40214	USD
	us-gaap	Interest Expense InterestExpense	63962	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
	us-gaap	Depreciation Depreciation	201143	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1660433	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3669465	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7493179	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1751016	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	1751016	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	3405	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	23032	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3823818	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1026706	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-48783	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-36801	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	174889	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-140200	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90547	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-327655	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1495169	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	28427	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	20770	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-103671	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-98678	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-37051	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-28426	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	43954	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5289961	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	171243	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	126975	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5298218	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-112500	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	10873	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	141883	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4249806	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25551201	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1661171	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14963022	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	310140	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1979311	USD
	us-gaap	Interest Paid InterestPaid	42854	USD
	us-gaap	Interest Paid InterestPaid	25495	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	482196	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1586691	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1217626	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	821121	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	143225	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	15188	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	519941	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	40214	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	24813000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	214169	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	vuzi	Common Stock Awards Compensation Expense CommonStockAwardsCompensationExpense	1475000	USD
	vuzi	Common Stock Awards Compensation Expense CommonStockAwardsCompensationExpense	0	USD
	vuzi	Common Stock Issued And Warrant Issued For Services Prepaid Expense CommonStockIssuedAndWarrantIssuedForServicesPrepaidExpense	843937	USD
	vuzi	Common Stock Issued And Warrant Issued For Services Prepaid Expense CommonStockIssuedAndWarrantIssuedForServicesPrepaidExpense	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	427500	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	vuzi	Reclassification Of Derivative Liability To Paidin Capital Upon Waiver Of Certain Antidilutive Provisions Of Warrants And Convertible Debt ReclassificationOfDerivativeLiabilityToPaidinCapitalUponWaiverOfCertainAntidilutiveProvisionsOfWarrantsAndConvertibleDebt	11543354	USD
	vuzi	Reclassification Of Derivative Liability To Paidin Capital Upon Waiver Of Certain Antidilutive Provisions Of Warrants And Convertible Debt ReclassificationOfDerivativeLiabilityToPaidinCapitalUponWaiverOfCertainAntidilutiveProvisionsOfWarrantsAndConvertibleDebt	0	USD
	vuzi	Reclassification Of Derivative Liability Upon Warrant Exercises ReclassificationOfDerivativeLiabilityUponWarrantExercises	2855463	USD
	vuzi	Reclassification Of Derivative Liability Upon Warrant Exercises ReclassificationOfDerivativeLiabilityUponWarrantExercises	0	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1260019	shares
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	101445	USD
CY2015Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	107474	USD
CY2014Q4	vuzi	Accrued Compensation AccruedCompensation	428786	USD
CY2015Q2	vuzi	Accrued Compensation AccruedCompensation	417286	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	45000	USD
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	52000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	39624	USD
CY2015Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	46663	USD
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8741	USD
CY2015Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	96414	USD
CY2014Q4	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	75471	USD
	vuzi	Officers Compensation Payable Compounding Monthly Interest Rate OfficersCompensationPayableCompoundingMonthlyInterestRate	0.08	pure
CY2015Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	71076	USD
CY2014Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	62801	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	8994	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	38032	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	45071	USD
CY2015Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	46663	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4168267	shares
	vuzi	Percentage Of Outstanding Warrants Issued By Parent PercentageOfOutstandingWarrantsIssuedByParent	0.86	pure
CY2014Q4	us-gaap	Convertible Debt ConvertibleDebt	3000000	USD
CY2015Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	45100	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	4730992	shares
CY2014Q2	vuzi	Fair Value Of Debt Embedded Conversion Price Adjustment Option FairValueOfDebtEmbeddedConversionPriceAdjustmentOption	1938988	USD
CY2015Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	5000000	USD
CY2015Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	5000000	USD
CY2015Q2	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	169027	USD
CY2015Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	169027	USD
CY2014Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	0	USD
CY2014Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	USD
CY2014Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	13541138	USD
CY2014Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2806942	USD
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10734196	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	107766	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	24393	USD
CY2015Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1902500	USD
CY2015Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2034659	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	874643	USD
CY2015Q2	us-gaap	Long Term Debt LongTermDebt	1160016	USD
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
	vuzi	Preferred Stock Shares Outstanding In Percent Liquidation Or Amendment Actions PreferredStockSharesOutstandingInPercentLiquidationOrAmendmentActions	0.6	pure
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5236660	shares
	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	4706517	shares
	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	60000	shares
CY2015Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	575329	shares
	vuzi	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	14814	shares
	vuzi	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms	P2Y8M12D
	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	2.40
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	347222	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.48
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	552329	shares
	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	3.69
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P9Y9M18D
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1843903	USD
CY2015Q2	us-gaap	Contractual Obligation ContractualObligation	40000	USD
CY2015Q2	vuzi	Prepaid Manufacturing Vendor Payments PrepaidManufacturingVendorPayments	843772	USD
CY2014Q4	vuzi	Prepaid Manufacturing Vendor Payments PrepaidManufacturingVendorPayments	156091	USD
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	49626	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	49626	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16001434	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16001434	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11295387	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11295387	shares
	vuzi	Increase Decrease In Vendors Prepayments IncreaseDecreaseInVendorsPrepayments	687681	USD
	vuzi	Increase Decrease In Vendors Prepayments IncreaseDecreaseInVendorsPrepayments	0	USD
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	941467	shares
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	39624	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	1217421	USD
CY2015Q2	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	335248	USD
	us-gaap	Description Of Lessor Leasing Arrangements Operating Leases DescriptionOfLessorLeasingArrangementsOperatingLeases	The Company leases office and manufacturing space under operating leases that expire on September 30, 2015 through to March 1, 2016.
	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P5Y
	us-gaap	Lessee Leasing Arrangements Operating Leases Renewal Term LesseeLeasingArrangementsOperatingLeasesRenewalTerm	P3Y
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	138090	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	3000000	USD
	vuzi	Discount On Senior Convertible Debt Attributed To Embedded Conversion Price Adjustment Option DiscountOnSeniorConvertibleDebtAttributedToEmbeddedConversionPriceAdjustmentOption	0	USD
	vuzi	Discount On Senior Convertible Debt Attributed To Embedded Conversion Price Adjustment Option DiscountOnSeniorConvertibleDebtAttributedToEmbeddedConversionPriceAdjustmentOption	1938988	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2015Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5000000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2015Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	376545	USD
CY2014Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	735483	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2778872	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	239110	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8228662	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1751016	USD
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15934279	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10285453	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14754298	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10135387	shares
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5000000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	5000000	USD
CY2015Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	735483	USD
CY2015Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	11580	USD
CY2014Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3405	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	23032	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3405	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px 0pt 34.55pt; FONT: 10pt Times New Roman, Times, Serif"> <b>Note 1  Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px 0pt 34.55pt; FONT: 10pt Times New Roman, Times, Serif"> <b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif"> The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2014 was derived from the audited Consolidated Financial Statements in Form 10-K.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif"> The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2014, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif"> The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD

Files In Submission

Name	View Source	Status
0001144204-15-049041-index-headers.html	Edgar Link	pending
0001144204-15-049041-index.html	Edgar Link	pending
0001144204-15-049041.txt	Edgar Link	pending
0001144204-15-049041-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v417226_10q.htm	Edgar Link	pending
v417226_ex31-1.htm	Edgar Link	pending
v417226_ex31-2.htm	Edgar Link	pending
v417226_ex32-1.htm	Edgar Link	pending
v417226_ex32-2.htm	Edgar Link	pending
vuzi-20150630.xml	Edgar Link	completed
vuzi-20150630.xsd	Edgar Link	pending
vuzi-20150630_cal.xml	Edgar Link	unprocessable
vuzi-20150630_def.xml	Edgar Link	unprocessable
vuzi-20150630_lab.xml	Edgar Link	unprocessable
vuzi-20150630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VUZI
Vuzix Corp Stock $vuzi

2015 Q2 Form 10-Q Financial Statement

#000114420415049041 Filed on August 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI Vuzix Corp Stock $vuzi

2015 Q2 Form 10-Q Financial Statement

#000114420415049041 Filed on August 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI
Vuzix Corp Stock $vuzi